Skip to main content
NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%
TR

TransMedics Group, Inc. (TMDX)

NASDAQ • Healthcare

$70.63
-$0.1 (-0.2%)
Market closed

Last close at October 26, 2026 at 20:00 UTC

Open$70.01
Day Range$69.61 - $71.97
Avg. Volume (3M)816.4K
Market Cap$2.4B
P/E Ratio16.0
52 Week Range
$60.11$156
Next EarningsIn 9 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$189.9M100%
Gross Profitminus cost of goods$113.1M60%
Operating Incomeminus R&D and overhead$23.7M12%
Net Incomeminus taxes and the rest$14.6M8%

In plain terms: out of every $100 in revenue, TransMedics Group, Inc. keeps $8 as net profit.

Fundamentals & Financials

Revenue (TTM)
$668.4M
Net Income (TTM)
$151.6M
EPS (TTM)
$4.42
ROA (TTM)
10.36%
Current Ratio
6.62

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+39.0%Q1 2026$0.57
-51.6%Q2 2026$0.3
-11.2%Q3 2026$0.44
Next

Nov 5

in 9 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -11.2%

TransMedics’ revenue beat expectations while adjusted EPS missed in the second fiscal quarter of 2026, results it reported on August 4, 2026, with revenue of $189.9 million topping the $184.0 million estimate (+3.2%) even as adjusted EPS of $0.44 trailed the $0.50 estimate (-11%). Revenue rose ~21% year over year to about $189.9 million (up from roughly $157.4 million a year ago), reflecting demand for the company’s Organ Care System organ-preservation and transplant-support platform. Profitability came through at a gross margin of ~60% and an operating margin of ~13%, with gross profit of about $113.2 million and operating income of roughly $23.7 million. Net income fell ~58% from the prior year to around $14.7 million (down from about $34.9 million a year ago), and adjusted EPS declined ~52% from $0.92 a year ago to $0.44. The quarter generated operating cash flow of roughly $17.3 million. Consensus for the next period calls for EPS of $0.30 on revenue of $177.4 million.

Next report — what to expect

TransMedics Group, Inc. (TMDX) reports earnings on November 4, 2026. Wall Street is looking for EPS of $0.294 on revenue of $176.9 million. For trailing context, revenue grew +20.7% year over year last quarter. TMDX has beaten EPS in 4 of 8 most recent quarters.

View full earnings history

About TransMedics Group, Inc.

TransMedics Group, Inc. develops and sells organ-preservation and transplant-support systems in the healthcare equipment field. Listed on the NASDAQ Global Market as TMDX, the company generated $605.5 million in FY2025 revenue from technology used to keep donor organs viable outside the human body under near-physiological conditions.

Name
TransMedics Group, Inc.
CEO
Waleed H. Hassanein
Website
www.transmedics.com
Industry
Healthcare
Year Founded
1998
Employees
898

Today's Snapshot

AI-generated

TMDX ended the day slightly lower at 70.63, in line with a flat sector. Earnings are due from TMDX on 5 November.

Trading Volume

Below 10d avg (888.9K)

828.9K

vs S&P 500 Today

Underperforming Market

-0.85%

Updated: October 26, 2026 at 20:11 UTC

Technical Indicators

0 Buy2 Neutral6 Sell
TMDX is technically weak, trading well below its short-, medium- and long-term moving averages while the classic pivot sits marginally above current levels, offering resistance. Momentum indicators including MACD and CCI are negative and ADX indicates a meaningful downtrend, while OBV shows distribution consistent with seller dominance. ATR is elevated, signaling larger intraday moves during the decline. Together these factors point to sustained technical pressure rather than stabilization. Technical takeaway: Strong Sell — trend, momentum and volume all favor downside continuation.
All signals
  • EMA (5 indicators)$73.43 - $97.62
    Sell
  • RSI (14)34.79
    Neutral
  • Stochastic %K (14, 3, 3)22.96
    Neutral
  • MACD Level (12, 26)-3.48
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.